EMPALIEVA 25 MG
Empagliflozin Tablets 25mg
EMPALIEVA 25 MG (Empagliflozin Tablets 25 mg) is a prescription medicine containing Empagliflozin 25 mg, an oral antidiabetic medication belonging to the Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor class. It is primarily used to improve blood sugar control in adults with Type 2 Diabetes Mellitus and is also associated with cardiovascular and kidney health benefits in appropriate patients. Empagliflozin works by blocking the SGLT2 protein in the kidneys, reducing glucose reabsorption and increasing the elimination of excess glucose through urine. This helps lower blood glucose levels independently of insulin while also supporting modest weight reduction and blood pressure control in many patients. EMPALIEVA 25 MG is commonly prescribed along with a healthy diet and regular exercise for adults with Type 2 Diabetes Mellitus. It may be used alone or in combination with other antidiabetic medicines as recommended by a healthcare professional. The medicine is taken orally and should be used exactly as prescribed by a qualified healthcare provider. EMPALIEVA 25 MG is commonly used for: Type 2 Diabetes Mellitus Blood Glucose Control Cardiovascular Risk Reduction in Eligible Patients Heart Failure Management (as advised by a physician) Chronic Kidney Disease Management (in appropriate patients) Combination Antidiabetic Therapy Long-Term Diabetes Management Manufactured according to stringent pharmaceutical quality standards, EMPALIEVA 25 MG is designed to provide consistent quality, safety, and therapeutic effectiveness. Patients receiving Empagliflozin therapy should undergo regular monitoring of blood glucose levels, kidney function, and overall health during treatment.
View Details